Literature DB >> 12655256

Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator.

Yuan-Chang Chung1, Ya-Fen Chang.   

Abstract

BACKGROUND: C-reactive protein (CRP) is an acute-phase protein synthesized in liver and up-regulated by pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor (TNF). Elevated CRP has been reported to be associated with reduced crude survival rates in patients with colorectal cancer.
OBJECTIVE: To investigate the prognostic significance of preoperative serum CRP in relation to the disease-specific survival rate and expression of different cytokines.
METHODS: One hundred and seventy-two consecutive patients with colorectal cancer, whose primary lesions were resected, were selected from April 1995 to December 1999. Preoperative serum CRP levels were measured, and the relationship between the elevation of CRP and clinicopathological factors was investigated. Prognostic significance was analysed by univariate and multivariate tests.
RESULTS: One-third of patients had increased CRP levels, and this was associated with larger tumour size, lymph node or liver metastasis, and advanced Dukes' stage. Higher CRP levels were also related to the elevation of IL-6 and IL-8. The most important prognostic factor predicting survival was Dukes' stage (P < 0.001). Multivariate analysis indicated that CRP level is not an independent factor predicting survival.
CONCLUSIONS: A preoperative elevation of serum CRP does not have the independent prognostic significance reported by earlier studies. Whether the elevated CRP can predict the development of cachexia or whether this association characterizes a pattern in tumour behaviour remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655256     DOI: 10.1097/00042737-200304000-00006

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  27 in total

1.  Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients.

Authors:  Michel Carlos Mocellin; Juliana de Aguiar Pastore e Silva; Carolina de Quadros Camargo; Maria Emília de Souza Fabre; Scheila Gevaerd; Katya Naliwaiko; Yara Maria Franco Moreno; Everson Araújo Nunes; Erasmo Benicio Santos de Moraes Trindade
Journal:  Lipids       Date:  2013-07-26       Impact factor: 1.880

2.  Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

Authors:  Nikolaos I Nikiteas; Nikolaos Tzanakis; Maria Gazouli; George Rallis; Kessaris Daniilidis; George Theodoropoulos; Alkiviadis Kostakis; George Peros
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

4.  A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.

Authors:  J-F Rossi; S Négrier; N D James; I Kocak; R Hawkins; H Davis; U Prabhakar; X Qin; P Mulders; B Berns
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

Review 5.  Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?

Authors:  Bassel Nazha; Elias Moussaly; Mazen Zaarour; Chanudi Weerasinghe; Basem Azab
Journal:  World J Gastrointest Surg       Date:  2015-12-27

6.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.

Authors:  Tadahiro Nozoe; Emiko Mori; Ikuo Takahashi; Takahiro Ezaki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

7.  Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.

Authors:  Hiroharu Yamashita; Joji Kitayama; Masataka Taguri; Hirokazu Nagawa
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

8.  Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study.

Authors:  Jie Wu; Qiuyin Cai; Honglan Li; Hui Cai; Jing Gao; Gong Yang; Wei Zheng; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Carcinogenesis       Date:  2013-08-28       Impact factor: 4.944

9.  Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections.

Authors:  Hartwig Kørner; Hans Jørgen Nielsen; Jon Arne Søreide; Bjørn S Nedrebø; Kjetil Søreide; Jens C Knapp
Journal:  J Gastrointest Surg       Date:  2009-05-29       Impact factor: 3.452

10.  Interleukin-8 producing hepatocellular carcinoma with pyrexia.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Kiyoshi Kajiyama; Takashi Nagaie; Tomonobu Gion; Yousuke Kuroda; Yoshihiko Maehara
Journal:  HPB Surg       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.